Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/30778
Full metadata record
DC FieldValueLanguage
dc.contributor.authorHussain, Tabinda-
dc.contributor.authorKallies, Axel-
dc.contributor.authorVasanthakumar, Ajithkumar-
dc.date2022-
dc.date.accessioned2022-09-06T06:46:55Z-
dc.date.available2022-09-06T06:46:55Z-
dc.date.issued2022-
dc.identifier.citationClinical & Translational Immunology 2022; 11(8): e1414en
dc.identifier.issn2050-0068
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/30778-
dc.description.abstractThis commentary article highlights two recently published studies, which for the first time revealed the immunological underpinnings of sex-bias in cancer incidence and mortality. These studies showed that the androgen receptor restrains anti-tumour immunity in males by repressing cytotoxic genes in CD8+ T cells.en
dc.language.isoeng
dc.titleSex-bias in CD8+ T-cell stemness and exhaustion in cancer.en
dc.typeJournal Articleen
dc.identifier.journaltitleClinical & Translational Immunologyen
dc.identifier.affiliationOlivia Newton-John Cancer Research Instituteen
dc.identifier.affiliationPeter Doherty Institute for Infection and Immunity Melbourne VIC Australiaen
dc.identifier.affiliationDepartment of Microbiology and Immunology University of Melbourne Melbourne VIC Australiaen
dc.identifier.affiliationLa Trobe University Bundoora VIC Australiaen
dc.identifier.doi10.1002/cti2.1414en
dc.type.contentTexten
dc.identifier.orcidhttps://orcid.org/0000-0002-1620-7781en
dc.identifier.pubmedid36051310
item.fulltextNo Fulltext-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.grantfulltextnone-
item.languageiso639-1en-
item.openairetypeJournal Article-
item.cerifentitytypePublications-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

24
checked on Jan 21, 2025

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.